Sales Down by 7.8% due to Slump of Long-Listed Drugs, Transfer of Marketing Rights for Cabaser: Kissei

According to consolidated first-half results for the April to September 2012 period released by Kissei Pharmaceutical on November 6, sales fell by 7.8% compared to the same period a year earlier to 29.321 billion yen due to a drop in...read more